首页 > 最新文献

The British journal of clinical practice最新文献

英文 中文
Acute admissions with atrial fibrillation in a British multiracial hospital population. 急性心房颤动入院在英国多种族医院人口。
J Zarifis, G Beevers, G Y Lip

To assess the clinical characteristics and management of patients with atrial fibrillation (AF), we performed a prospective survey of all acute medical admissions over six months to our hospital. Of 7,451 such admissions, 245 had AF (110 male, 135 female; mean age 74.4 years). Of these, 213 were Caucasian, 10 black/Afro-Caribbean and 22 Asian. Complete data were available for 185 patients. Of these, 82 had newly diagnosed AF, 83 had previous chronic AF and 20 had paroxysmal AF. The main presenting features was dyspnoea, stroke and syncope. A history of ischaemic heart disease was present in 64, heart failure in 46, hypertension in 51 and rheumatic heart disease in 13, while 31 had a previous stroke. Chest X-ray showed cardiomegaly and pulmonary oedema in 121 patients, but was normal in 28. Echocardiography showed poor cardiac function in eight patients and enlarged left atria in five. Only 28% of those with previously diagnosed AF were on anticoagulation. Of the newly diagnosed patients, only 18% were started on anticoagulants. Cardioversion was attempted or planned in only 6%. The primary diagnosis on discharge was heart failure in 45, stroke in 24 and myocardial infarction in 12. AF remains a common arrhythmia among acute medical admissions and is commonly associated with heart failure and a high mortality. There is still a reluctance to start anticoagulant therapy or to perform cardioversion in such patients.

为了评估心房颤动(AF)患者的临床特征和处理,我们对所有在我院住院6个月以上的急性住院患者进行了前瞻性调查。在7451例此类入院患者中,245例患有房颤(男性110例,女性135例;平均年龄74.4岁)。其中,213人是白种人,10人是黑人/非裔加勒比人,22人是亚洲人。185例患者的完整数据。其中82例为新诊断的房颤,83例为既往慢性房颤,20例为阵发性房颤。主要表现为呼吸困难、中风和晕厥。有缺血性心脏病史的64人,有心力衰竭史的46人,有高血压史的51人,有风湿性心脏病史的13人,有中风史的31人。胸片显示121例患者心脏肿大、肺水肿,28例正常。超声心动图显示8例心功能差,5例左心房增大。在先前诊断为房颤的患者中,只有28%的人接受了抗凝治疗。在新诊断的患者中,只有18%的人开始使用抗凝剂。只有6%的人试图或计划复律。出院时主要诊断为心力衰竭45例,中风24例,心肌梗死12例。房颤仍然是急性住院患者中常见的心律失常,通常与心力衰竭和高死亡率有关。这类患者仍不愿开始抗凝治疗或进行心脏复律。
{"title":"Acute admissions with atrial fibrillation in a British multiracial hospital population.","authors":"J Zarifis,&nbsp;G Beevers,&nbsp;G Y Lip","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>To assess the clinical characteristics and management of patients with atrial fibrillation (AF), we performed a prospective survey of all acute medical admissions over six months to our hospital. Of 7,451 such admissions, 245 had AF (110 male, 135 female; mean age 74.4 years). Of these, 213 were Caucasian, 10 black/Afro-Caribbean and 22 Asian. Complete data were available for 185 patients. Of these, 82 had newly diagnosed AF, 83 had previous chronic AF and 20 had paroxysmal AF. The main presenting features was dyspnoea, stroke and syncope. A history of ischaemic heart disease was present in 64, heart failure in 46, hypertension in 51 and rheumatic heart disease in 13, while 31 had a previous stroke. Chest X-ray showed cardiomegaly and pulmonary oedema in 121 patients, but was normal in 28. Echocardiography showed poor cardiac function in eight patients and enlarged left atria in five. Only 28% of those with previously diagnosed AF were on anticoagulation. Of the newly diagnosed patients, only 18% were started on anticoagulants. Cardioversion was attempted or planned in only 6%. The primary diagnosis on discharge was heart failure in 45, stroke in 24 and myocardial infarction in 12. AF remains a common arrhythmia among acute medical admissions and is commonly associated with heart failure and a high mortality. There is still a reluctance to start anticoagulant therapy or to perform cardioversion in such patients.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"91-6"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impotence and its non-surgical management. 阳痿及其非手术治疗。
A J Riley, L Athanasiadis

Impotence is a common symptom which can cause considerable distress to both the sufferer and his partner. The use of pharmacotherapy to improve erectile function will continue to increase as safe and effective drugs are developed. However, restoring erectile function should not be the only treatment objective. It is also essential to address personal and emotional factors in the sufferer, conflicts in his relationship with his partner, and sexual problems in his partner, all of which may be instrumental in causing or maintaining the presenting impotence. We advocate a combined approach with appropriate medical treatment and sex and couple therapy.

阳痿是一种常见的症状,会给患者和他的伴侣造成相当大的痛苦。随着安全有效药物的开发,改善勃起功能的药物治疗将继续增加。然而,恢复勃起功能不应该是唯一的治疗目标。同样重要的是要解决患者的个人和情感因素,他与伴侣的关系冲突,以及他伴侣的性问题,所有这些都可能导致或维持阳痿。我们提倡结合适当的医疗和性及夫妻治疗。
{"title":"Impotence and its non-surgical management.","authors":"A J Riley,&nbsp;L Athanasiadis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Impotence is a common symptom which can cause considerable distress to both the sufferer and his partner. The use of pharmacotherapy to improve erectile function will continue to increase as safe and effective drugs are developed. However, restoring erectile function should not be the only treatment objective. It is also essential to address personal and emotional factors in the sufferer, conflicts in his relationship with his partner, and sexual problems in his partner, all of which may be instrumental in causing or maintaining the presenting impotence. We advocate a combined approach with appropriate medical treatment and sex and couple therapy.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"99-103, 105"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-acquired lower respiratory tract infection: implementation of an antibiotic protocol. 社区获得性下呼吸道感染:抗生素方案的实施。
I B Menown, J A Archbold, K B Bamford, P M Bell, M E Callender

Enthusiastic formulation of clinical guidelines continues to increase but although theoretical difficulties in guideline implementation have been recognised, little attention has been paid to their effectiveness in everyday clinical practice. The introduction of a protocol for empirical treatment of lower respiratory tract infection (PETRI) to an acute medical take-in unit in Belfast is described. Early involvement of all relevant staff, preparation of user-friendly flow charts, and imaginative publicity, resulted in an initial implementation rate of 75%. The role of implementation as a significant rate-limiting step in the audit cycle is emphasised.

热心制定临床指南的人数不断增加,但尽管已经认识到指南实施中的理论困难,但很少注意到它们在日常临床实践中的有效性。介绍了一项协议的经验治疗下呼吸道感染(PETRI)的急性医疗接收单位在贝尔法斯特描述。所有相关人员的早期参与,编写方便用户的流程图,以及富有想象力的宣传,使初步执行率达到75%。强调执行在审计周期中作为限制比率的重要步骤的作用。
{"title":"Community-acquired lower respiratory tract infection: implementation of an antibiotic protocol.","authors":"I B Menown,&nbsp;J A Archbold,&nbsp;K B Bamford,&nbsp;P M Bell,&nbsp;M E Callender","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Enthusiastic formulation of clinical guidelines continues to increase but although theoretical difficulties in guideline implementation have been recognised, little attention has been paid to their effectiveness in everyday clinical practice. The introduction of a protocol for empirical treatment of lower respiratory tract infection (PETRI) to an acute medical take-in unit in Belfast is described. Early involvement of all relevant staff, preparation of user-friendly flow charts, and imaginative publicity, resulted in an initial implementation rate of 75%. The role of implementation as a significant rate-limiting step in the audit cycle is emphasised.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"74-7"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current surgical treatment of Dupuytren's disease. Dupuytren病的外科治疗现状。
G R Wilson

The practice of surgery for Dupuytren's contracture is changing. Most surgery can be carried out under regional or local anaesthesia on a day case basis. Although the commonest surgery performed is partial fasciectomy, there is more a polarisation developing with minimal surgery (e.g. segmental fasciectomy) for early disease and more aggressive surgery (dermofasciectomy) for advanced and recurrent disease.

手术治疗Dupuytren挛缩的方法正在发生变化。大多数手术可以在区域或局部麻醉下进行,以一天为基础。虽然最常见的手术是部分筋膜切除术,但对于早期疾病的小手术(如节段性筋膜切除术)和晚期和复发疾病的更积极的手术(皮筋膜切除术)更容易出现两极分化。
{"title":"Current surgical treatment of Dupuytren's disease.","authors":"G R Wilson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The practice of surgery for Dupuytren's contracture is changing. Most surgery can be carried out under regional or local anaesthesia on a day case basis. Although the commonest surgery performed is partial fasciectomy, there is more a polarisation developing with minimal surgery (e.g. segmental fasciectomy) for early disease and more aggressive surgery (dermofasciectomy) for advanced and recurrent disease.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"106-10"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interferons in oncology. 肿瘤学中的干扰素。
P J Woll, R Pettengell

The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation.

干扰素是一种天然的糖蛋白,在各种刺激下分泌,包括病毒感染。它们对不同的靶细胞群具有抗病毒、抗增殖和免疫调节作用。自从重组人干扰素可用以来,它们已经在各种恶性肿瘤中进行了测试。它们在毛细胞白血病、慢性骨髓性白血病和多发性骨髓瘤的治疗中得到了很好的证实。虽然它们对淋巴瘤、黑色素瘤、肾细胞癌和类癌肿瘤有治疗作用,但它们在治疗这些肿瘤中的作用尚不清楚。对于常见的实体肿瘤,如肺癌和结直肠癌,干扰素的使用仍处于试验阶段。在这里,我们将总结它们在肿瘤学中的实践应用,使用随机研究来确定它们在多模式治疗中的地位。我们不会讨论它们在病毒性和自身免疫性疾病、多发性硬化症或器官移植后作为抗病毒或免疫调节剂的用途。
{"title":"Interferons in oncology.","authors":"P J Woll,&nbsp;R Pettengell","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"111-5"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20105759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron deficiency anaemia in general practice: presentations and investigations. 缺铁性贫血的一般做法:介绍和调查。
A J Stellon, S E Kenwright

Twenty-six patients over the age of 50 years with proven iron deficiency anaemia were identified, investigated and followed up in general practice over a five-year period. The anaemia was symptomatic in 50% of patients but only 20% had symptoms related to the gut. Faecal occult blood testing was positive in five patients only and negative tests occurred in three patients with significant disease, including one caecal carcinoma. All patients agreed to oesophagogastroduodenoscopy (OGD) and fibreoptic sigmoidoscopy carried out on the same occasion. In eight patients, significant abnormalities were found on OGD and in two patients on sigmoidoscopy. Four patients declined barium enema examinations, two of whom had significant OGD abnormalities. Barium enema examination of the other 22 patients showed polyposis of the colon and a caecal carcinoma and initially missed one carcinoma of the caecum which was found subsequently. The likelihood of finding significant disease in iron-deficient patients over 50 years of age is high and should be assumed to be due to blood loss into the gut. Investigation by OGD, sigmoidoscopy and barium enema in the first instance seems warranted and is a condition that can be safely managed by the GP.

对26例50岁以上的缺铁性贫血患者进行了鉴定、调查和随访,为期5年。50%的患者有贫血症状,但只有20%的患者有与肠道有关的症状。只有5例患者的粪便隐血试验呈阳性,3例患者的重大疾病(包括1例盲肠癌)出现阴性。所有患者均同意在同一时间进行食管胃十二指肠镜检查(OGD)和纤维乙状结肠镜检查。8例患者在OGD上发现明显异常,2例在乙状结肠镜下发现明显异常。4例患者拒绝钡灌肠检查,其中2例有明显的OGD异常。其余22例患者的钡灌肠检查显示结肠息肉和盲肠癌,最初遗漏了一个盲肠癌,随后发现。在50岁以上的缺铁患者中发现重大疾病的可能性很高,应假定是由于失血进入肠道。首先通过OGD,乙状结肠镜检查和钡灌肠进行检查似乎是合理的,并且是一种可以由全科医生安全处理的情况。
{"title":"Iron deficiency anaemia in general practice: presentations and investigations.","authors":"A J Stellon,&nbsp;S E Kenwright","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Twenty-six patients over the age of 50 years with proven iron deficiency anaemia were identified, investigated and followed up in general practice over a five-year period. The anaemia was symptomatic in 50% of patients but only 20% had symptoms related to the gut. Faecal occult blood testing was positive in five patients only and negative tests occurred in three patients with significant disease, including one caecal carcinoma. All patients agreed to oesophagogastroduodenoscopy (OGD) and fibreoptic sigmoidoscopy carried out on the same occasion. In eight patients, significant abnormalities were found on OGD and in two patients on sigmoidoscopy. Four patients declined barium enema examinations, two of whom had significant OGD abnormalities. Barium enema examination of the other 22 patients showed polyposis of the colon and a caecal carcinoma and initially missed one carcinoma of the caecum which was found subsequently. The likelihood of finding significant disease in iron-deficient patients over 50 years of age is high and should be assumed to be due to blood loss into the gut. Investigation by OGD, sigmoidoscopy and barium enema in the first instance seems warranted and is a condition that can be safely managed by the GP.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"78-80"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variability in post-operative fluid and electrolyte prescription. 术后液体和电解质处方的可变性。
M D Stoneham, E L Hill

A four-week retrospective survey of intravenous fluid and electrolyte prescriptions on post-operative surgical patients revealed wide variability in fluid and electrolyte prescription by medical staff. Median volume of intravenous fluid prescribed was 3000 ml (range 1667-5000). Total sodium prescribed varied from 0 to 770, median 242 mmol/day), with potassium infrequently added (range 0-81, median 0 mmol/day). Patients undergoing emergency surgery were prescribed more sodium than those undergoing routine procedures (p = 0.0403); 0.9% saline was the most common fluid prescribed overall. There was poor correlation between serum electrolyte values and the amounts of electrolytes prescribed. Intravenous fluid prescription should take into account the post-operative stress response which reduces sodium requirements (unless there are other concomitant losses) and increases urinary potassium losses. A suitable post-operative 'maintenance' fluid is 4% dextrose/0.18% saline with 1-2 g potassium chloride, particularly if serum electrolyte levels are not known. Other fluid losses should be replaced with equivalent fluids.

一项对术后患者静脉输液和电解质处方的为期四周的回顾性调查显示,医务人员在输液和电解质处方方面存在很大差异。静脉液体处方的中位容量为3000毫升(范围1667-5000)。总钠处方从0到770,中位数为242 mmol/天),很少添加钾(范围从0到81,中位数为0 mmol/天)。接受紧急手术的患者比接受常规手术的患者服用更多的钠(p = 0.0403);总体而言,0.9%生理盐水是最常见的处方液体。血清电解质值与处方电解质量之间相关性较差。静脉输液处方应考虑到术后应激反应,这会降低钠的需水量(除非有其他伴随损失)并增加尿钾的损失。术后适当的“维持”液为4%葡萄糖/0.18%生理盐水加1-2 g氯化钾,特别是在血清电解质水平未知的情况下。其他流失的液体应替换为同等的液体。
{"title":"Variability in post-operative fluid and electrolyte prescription.","authors":"M D Stoneham,&nbsp;E L Hill","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A four-week retrospective survey of intravenous fluid and electrolyte prescriptions on post-operative surgical patients revealed wide variability in fluid and electrolyte prescription by medical staff. Median volume of intravenous fluid prescribed was 3000 ml (range 1667-5000). Total sodium prescribed varied from 0 to 770, median 242 mmol/day), with potassium infrequently added (range 0-81, median 0 mmol/day). Patients undergoing emergency surgery were prescribed more sodium than those undergoing routine procedures (p = 0.0403); 0.9% saline was the most common fluid prescribed overall. There was poor correlation between serum electrolyte values and the amounts of electrolytes prescribed. Intravenous fluid prescription should take into account the post-operative stress response which reduces sodium requirements (unless there are other concomitant losses) and increases urinary potassium losses. A suitable post-operative 'maintenance' fluid is 4% dextrose/0.18% saline with 1-2 g potassium chloride, particularly if serum electrolyte levels are not known. Other fluid losses should be replaced with equivalent fluids.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"82-4"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiographic benefits from lipid-lowering in the clinical context. 血管造影在临床中受益于降脂。
G Jackson
{"title":"Angiographic benefits from lipid-lowering in the clinical context.","authors":"G Jackson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"67-8"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20104588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimising the medical management of benign prostatic hyperplasia. 优化良性前列腺增生的医疗管理。
T McDermott

The ageing population is presenting an increasing demand on future healthcare services. In males, prostatic disease is one of the commonest disorders contributing to this. Alternatives to surgical intervention have to be considered as the preferred option for individuals and whether this be a therapeutic or a financial option to be taken. Two major medical alternatives are alpha-blockers and 5-alpha reductase inhibitors. The results of such treatment can be very beneficial in selected groups of patients. Side-effects with improved drugs electivity are reducing. Overall, while surgery still holds the gold standard, medical therapy has a significant role in the treatment of benign prostatic hypertrophy. Cost analysis may be a factor in deciding which treatment to have.

人口老龄化对未来医疗保健服务的需求日益增加。在男性中,前列腺疾病是最常见的疾病之一。手术干预的替代方案必须被视为个人的首选方案,无论这是治疗方案还是经济方案。两种主要的医学替代品是α -受体阻滞剂和5- α还原酶抑制剂。这种治疗的结果对特定的患者群体是非常有益的。随着药物选择性的提高,副作用正在减少。总的来说,虽然手术仍然是金标准,但药物治疗在治疗良性前列腺肥大中起着重要作用。成本分析可能是决定采用哪种治疗的一个因素。
{"title":"Optimising the medical management of benign prostatic hyperplasia.","authors":"T McDermott","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The ageing population is presenting an increasing demand on future healthcare services. In males, prostatic disease is one of the commonest disorders contributing to this. Alternatives to surgical intervention have to be considered as the preferred option for individuals and whether this be a therapeutic or a financial option to be taken. Two major medical alternatives are alpha-blockers and 5-alpha reductase inhibitors. The results of such treatment can be very beneficial in selected groups of patients. Side-effects with improved drugs electivity are reducing. Overall, while surgery still holds the gold standard, medical therapy has a significant role in the treatment of benign prostatic hypertrophy. Cost analysis may be a factor in deciding which treatment to have.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"116-8"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20105760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An incidental finding of Gitelman's syndrome. 偶然发现的吉特尔曼综合征。
M B Leonard, D Neithercut

Gitelman's syndrome is characterised by hypokalaemia, hypomagnesaemia and tetany. This rare disorder is not well described in the literature, probably due to its similarity with Bartter's syndrome. We describe the symptoms and treatment of a young patient whom we consider to have Gitelman's syndrome.

吉特曼综合征的特点是低钾血症、低镁血症和手足搐搦症。这种罕见的疾病在文献中没有很好地描述,可能是因为它与巴特综合征相似。我们描述的症状和治疗的一个年轻的病人,我们认为有吉特尔曼综合征。
{"title":"An incidental finding of Gitelman's syndrome.","authors":"M B Leonard,&nbsp;D Neithercut","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gitelman's syndrome is characterised by hypokalaemia, hypomagnesaemia and tetany. This rare disorder is not well described in the literature, probably due to its similarity with Bartter's syndrome. We describe the symptoms and treatment of a young patient whom we consider to have Gitelman's syndrome.</p>","PeriodicalId":22312,"journal":{"name":"The British journal of clinical practice","volume":"51 2","pages":"121-4"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20105762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The British journal of clinical practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1